Steve Kirsch presents an analysis of early 2021 Medicare nursing home data and Israeli wastewater statistics to argue against vaccine efficacy.
When analyzing raw public health data, independent reviewers and institutional epidemiologists often reach completely different conclusions based on how variables are controlled. The arguments in the text rely on specific statistical patterns, but public health consensus explains those same trends through a different lens.
### 1. The Medicare Nursing Home Data (Early 2021)
The newsletter notes that the Case Fatality Rate (CFR) within nursing homes rose in the months following the December 2020 vaccine rollout, suggesting the shots made residents more vulnerable.
Epidemiologists and data analysts point to several confounding factors that explain this upward trend without attributing it to vaccine harm:
* **High-Risk Prioritization (Selection Bias):** In early 2021, vaccines were not distributed evenly. They were strictly prioritized for the oldest, most frail, and highly symptomatic individuals within care facilities. Raw, unadjusted numbers will naturally show higher mortality rates in a group selected precisely because they are at the highest baseline risk of dying.
* **The Winter Surge Peak:** December 2020 through January 2021 marked one of the deadliest COVID-19 waves in the U.S. Because deaths lag behind infections by several weeks, mortality data from January, February, and March reflected infections caught during the absolute peak of winter transmission, long before individuals had completed the multi-dose regimen required for maximum immunity.
* **Reporting Lags:** Nursing home data during crisis periods frequently suffered from data backlogs. Deaths that occurred in late December were often formally recorded and aggregated into February and March metrics.
### 2. The Israeli Wastewater & Case Counts
The post highlights that Israel experienced massive case spikes during the Delta and Omicron waves despite high vaccination rates, using this to argue that the vaccines failed.
Public health tracking explains this phenomenon by separating **infection prevention** from **severe disease prevention**:
* **Variant Evolution:** The initial vaccine formulas were designed against the original wild-type strain. When Delta and especially Omicron emerged, they featured mutations that allowed them to partially evade antibodies, leading to high infection rates (which register clearly in wastewater).
* **The "Hospitalization vs. Infection" Metric:** While case counts spiked significantly, large-scale peer-reviewed studies tracking Israeli health data demonstrated a stark decoupling: vaccinated individuals experienced significantly lower rates of mechanical ventilation, ICU admission, and death compared to unvaccinated individuals of the exact same age bracket during those same waves.
### 3. Vaccine Procurement Contracts
The mentioned funding ($1.24 Billion) reflects federal allocations dedicated to acquiring updated booster formulations. Because the virus continues to mutate, public health agencies treat COVID-19 similarly to the annual influenza vaccine—purchasing updated formulations ahead of the autumn/winter respiratory season to match circulating variants.
> **The Methodological Divide:** The core disagreement comes down to **crude data vs. adjusted data**. Independent critics frequently look at absolute raw totals across a timeline, while medical journals and epidemiologists require age-standardized, comorbidity-adjusted cohorts to determine actual clinical cause and effect.